PubMed:29026098 / 0-207 JSONTXT

{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":54,"end":76},"obj":"Cell"},{"id":"T2","span":{"begin":160,"end":181},"obj":"Cell"},{"id":"T3","span":{"begin":172,"end":181},"obj":"Cell"},{"id":"T4","span":{"begin":183,"end":187},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0002248"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0002248"},{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0000034"},{"id":"A4","pred":"cl_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL:0002195"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":14,"end":19},"obj":"Body_part"},{"id":"T3","span":{"begin":66,"end":76},"obj":"Body_part"},{"id":"T4","span":{"begin":172,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000185"},{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000185"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":48,"end":53},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":154,"end":159},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"},{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":54,"end":76},"obj":"Cell"},{"id":"T2","span":{"begin":160,"end":181},"obj":"Cell"},{"id":"T3","span":{"begin":172,"end":181},"obj":"Cell"},{"id":"T4","span":{"begin":183,"end":187},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0002248"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0002248"},{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0000034"},{"id":"A4","pred":"cl_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL:0002195"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":14,"end":19},"obj":"Body_part"},{"id":"T2","span":{"begin":54,"end":76},"obj":"Body_part"},{"id":"T3","span":{"begin":160,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL_0002248"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0002248"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":14,"end":19},"obj":"Body_part"},{"id":"T3","span":{"begin":66,"end":76},"obj":"Body_part"},{"id":"T4","span":{"begin":172,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000185"},{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000185"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":99},"obj":"Sentence"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":48,"end":53},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":154,"end":159},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"},{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":14,"end":19},"obj":"Body_part"},{"id":"T2","span":{"begin":54,"end":76},"obj":"Body_part"},{"id":"T3","span":{"begin":160,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL_0002248"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0002248"}],"text":"HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.\nOne prerequisite for a successful clinical outcome of human pluripotent stem cell (hPSC) based therapies is"}